TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.7214
+0.0014 (0.19%)
Jul 2, 2026, 4:00 PM EDT - Market closed
TELA Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 80.81 | 80.28 | 69.3 | 58.45 | 41.42 | 29.46 | |
Revenue Growth (YoY) | 13.48% | 15.84% | 18.56% | 41.13% | 40.58% | 61.77% |
Cost of Revenue | 26.09 | 25.55 | 22.43 | 17.96 | 13.57 | 10.35 |
Gross Profit | 54.35 | 54.34 | 46.49 | 40.11 | 27.04 | 18.81 |
Selling, General & Admin | 79.14 | 78.88 | 79.37 | 74.57 | 57.11 | 41.52 |
Research & Development | 9.02 | 9.22 | 8.81 | 9.62 | 8.94 | 6.74 |
Other Operating Expenses | - | - | -7.58 | - | - | - |
Total Operating Expenses | 88.16 | 88.1 | 80.6 | 84.19 | 66.05 | 48.26 |
Operating Income | -33.81 | -33.76 | -34.12 | -44.08 | -39.01 | -29.45 |
Interest Expense | -6.08 | -5.25 | -5.29 | -5.22 | -4.05 | -3.6 |
Other Non-Operating Income (Expense) | 1.17 | 0.4 | 1.42 | 2.63 | -1.24 | - |
Total Non-Operating Income (Expense) | -4.91 | -4.85 | -3.87 | -2.59 | -5.29 | -3.6 |
Pretax Income | -39.6 | -38.6 | -37.99 | -46.66 | -44.3 | -33.05 |
Provision for Income Taxes | 0.24 | 0.23 | -0.14 | - | - | - |
Net Income | -39.84 | -38.83 | -37.84 | -46.66 | -44.3 | -33.28 |
Net Income to Common | -39.84 | -38.83 | -37.84 | -46.66 | -44.3 | -33.28 |
Shares Outstanding (Basic) | 50 | 47 | 29 | 23 | 16 | 14 |
Shares Outstanding (Diluted) | 50 | 47 | 29 | 23 | 16 | 14 |
Shares Change (YoY) | 48.27% | 64.58% | 24.74% | 40.58% | 12.40% | 11.90% |
EPS (Basic) | -0.79 | -0.83 | -1.33 | -2.04 | -2.72 | -2.30 |
EPS (Diluted) | -0.79 | -0.83 | -1.33 | -2.04 | -2.72 | -2.30 |
Free Cash Flow | -30.2 | -28.67 | -42.58 | -41.47 | -41.62 | -31.06 |
Free Cash Flow Per Share | -0.60 | -0.61 | -1.49 | -1.81 | -2.56 | -2.15 |
Gross Margin | 67.25% | 67.69% | 67.08% | 68.62% | 65.30% | 63.85% |
Operating Margin | -41.84% | -42.05% | -49.23% | -75.40% | -94.18% | -99.96% |
Profit Margin | -49.30% | -48.37% | -54.60% | -79.83% | -106.95% | -112.94% |
FCF Margin | -37.37% | -35.71% | -61.45% | -70.94% | -100.49% | -105.42% |
EBITDA | -32.8 | -32.75 | -33.1 | -43.27 | -37.82 | -28.92 |
EBITDA Margin | -40.59% | -40.79% | -47.77% | -74.02% | -91.31% | -98.14% |
EBIT | -33.81 | -33.76 | -34.12 | -44.08 | -39.01 | -29.45 |
EBIT Margin | -41.84% | -42.05% | -49.23% | -75.40% | -94.18% | -99.96% |
Effective Tax Rate | -0.60% | -0.60% | 0.38% | 0.00% | 0.00% | 0.00% |